Sign in

You're signed outSign in or to get full access.

Artem Chubar

Research Analyst at Rothschild & Co Redburn

Artem Chubar is an analyst at Rothschild & Co Redburn, specializing in equity research with a focus on specialty chemicals and related sectors. He covers companies such as Balchem Corporation, actively participating in earnings calls to analyze topics like tariffs, market positions, tax rates, FX impacts, and capital deployment priorities. Chubar's career details at Rothschild & Co Redburn are not fully specified in available sources, with no public performance metrics, rankings, success rates, or quantitative returns identified; his professional credentials including FINRA registrations or licenses are also unavailable.

Artem Chubar's questions to BALCHEM (BCPC) leadership

Question · Q4 2025

Artem Chubar inquired about the performance dynamics within Balchem's Human Nutrition & Health (H&H) segment, specifically comparing nutrients versus food ingredients, and within the Animal Nutrition & Health (ANH) segment, contrasting ruminant versus monogastric growth.

Answer

Chairman, President, and CEO Ted Harris explained that H&H dynamics haven't significantly shifted recently, but over the last year, food ingredients and solutions growth increased to about 4% due to 'better-for-you' trends, while minerals and nutrients maintained strong double-digit growth. In ANH, he noted that ruminant business remains the primary growth driver, with the monogastric business now recovering and showing some growth after a period of no or negative growth in 2024, contributing to overall higher ANH growth.

Ask follow-up questions

Fintool

Fintool can predict BALCHEM logo BCPC's earnings beat/miss a week before the call

Question · Q4 2025

Artem Chubar asked for details on performance dynamics within the Human Nutrition and Health (H&H) segment, specifically comparing growth in nutrients versus food ingredients to Q3, and similar insights for the Animal Nutrition and Health (ANH) segment, differentiating between ruminant and monogastric businesses.

Answer

Chairman, President, and CEO Ted Harris clarified that H&H dynamics haven't significantly shifted in recent quarters, but over the last year, food ingredients and solutions have seen higher growth due to 'better-for-you' trends, while minerals and nutrients continue strong double-digit growth. For ANH, he noted that ruminant business remains the primary growth driver, now coupled with improved growth in the monogastric business, which had previously seen no or negative growth in 2024 due to European market conditions.

Ask follow-up questions

Fintool

Fintool can write a report on BALCHEM logo BCPC's next earnings in your company's style and formatting